VPREB1 and plasma cell myeloma: Accordingly, we hypothesized that if we are able to in-vitro knock-out the VPREB1 gene in myeloma cells using specific guide RNA sequence linked to CRISPR/Cas9 nuclease, the VPREB1 protein expression is reduced and therefore we can inhibit the proliferation of human myeloma cells.